The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product Gadavist 7.5 mmol/7.5 ml vial. The firm-fixed-price contract has a ceiling value of $2,957.51 and is set to expire on April 26, 2024. This order is placed under Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract was awarded on a full and open competition basis without any set-aside designations.
Generated 7/25/24, 9:59 AM